RU94043771A - Замещенные бензимидазольные соединения, способ лечения, фармацевтическая композиция и способ получения бензимидазольных соединений - Google Patents
Замещенные бензимидазольные соединения, способ лечения, фармацевтическая композиция и способ получения бензимидазольных соединенийInfo
- Publication number
- RU94043771A RU94043771A RU94043771/04A RU94043771A RU94043771A RU 94043771 A RU94043771 A RU 94043771A RU 94043771/04 A RU94043771/04 A RU 94043771/04A RU 94043771 A RU94043771 A RU 94043771A RU 94043771 A RU94043771 A RU 94043771A
- Authority
- RU
- Russia
- Prior art keywords
- benzimidazole compounds
- virus
- synthesis
- pharmaceutical composition
- compounds
- Prior art date
Links
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title abstract 3
- 238000000034 method Methods 0.000 title 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims abstract 6
- 150000001875 compounds Chemical class 0.000 claims abstract 5
- 230000000694 effects Effects 0.000 claims abstract 3
- 241000700605 Viruses Species 0.000 claims abstract 2
- 229910052736 halogen Inorganic materials 0.000 claims abstract 2
- 125000005843 halogen group Chemical group 0.000 claims abstract 2
- 241001529453 unidentified herpesvirus Species 0.000 claims abstract 2
- 208000002672 hepatitis B Diseases 0.000 claims 1
- 241000700721 Hepatitis B virus Species 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 125000002837 carbocyclic group Chemical group 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000002777 nucleoside Substances 0.000 abstract 1
- 150000003833 nucleoside derivatives Chemical class 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
К особенно предпочтительным соединениям относятся такие, в которых положения 2, 5 и 6 имидазольного основания замещены галогеном. Соединения обладают активностью против вируса герпеса, особенно вируса цитомегалии, а также против инфекций вирусом гепатита В.
Claims (1)
- К особенно предпочтительным соединениям относятся такие, в которых положения 2, 5 и 6 имидазольного основания замещены галогеном. Соединения обладают активностью против вируса герпеса, особенно вируса цитомегалии, а также против инфекций вирусом гепатита В.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9205071.5 | 1992-03-09 | ||
GB929205071A GB9205071D0 (en) | 1992-03-09 | 1992-03-09 | Therapeutic nucleosides |
PCT/GB1993/000479 WO1993018009A1 (en) | 1992-03-09 | 1993-03-08 | Antiviral nucleoside analogues |
Publications (2)
Publication Number | Publication Date |
---|---|
RU94043771A true RU94043771A (ru) | 1996-08-10 |
RU2141952C1 RU2141952C1 (ru) | 1999-11-27 |
Family
ID=10711750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU94043771A RU2141952C1 (ru) | 1992-03-09 | 1993-03-08 | Замещенные бензимидазольные соединения, способы получения и фармацевтическая композиция на их основе, обладающая антивирусным действием |
Country Status (20)
Country | Link |
---|---|
US (1) | US5534535A (ru) |
EP (1) | EP0630368B1 (ru) |
JP (1) | JP3450854B2 (ru) |
KR (2) | KR950700887A (ru) |
AT (1) | ATE170846T1 (ru) |
AU (1) | AU672597B2 (ru) |
CA (1) | CA2131693A1 (ru) |
CZ (1) | CZ209494A3 (ru) |
DE (1) | DE69320945T2 (ru) |
DK (1) | DK0630368T3 (ru) |
ES (1) | ES2123048T3 (ru) |
FI (1) | FI944134A (ru) |
GB (1) | GB9205071D0 (ru) |
HU (1) | HUT68445A (ru) |
IL (1) | IL104976A (ru) |
NZ (1) | NZ249554A (ru) |
RU (1) | RU2141952C1 (ru) |
TW (1) | TW366339B (ru) |
WO (1) | WO1993018009A1 (ru) |
ZA (1) | ZA931647B (ru) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9205071D0 (en) * | 1992-03-09 | 1992-04-22 | Wellcome Found | Therapeutic nucleosides |
GB9413724D0 (en) | 1994-07-07 | 1994-08-24 | Wellcome Found | Therapeutic nucleosides |
AP741A (en) * | 1994-09-09 | 1999-04-26 | The Wellcome Foundation Ltd | Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring. |
US5811073A (en) * | 1995-06-19 | 1998-09-22 | President And Fellows Of Harvard College | Method for radioisotopic detection and localization of inflammation in a host |
US5912356A (en) * | 1995-09-11 | 1999-06-15 | Glaxo Wellcome Inc. | Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring |
GB9600143D0 (en) | 1996-01-05 | 1996-03-06 | Wellcome Found | Therapeutic compounds |
GB9600142D0 (en) * | 1996-01-05 | 1996-03-06 | Wellcome Found | Chemical compounds |
US6413938B1 (en) | 1997-02-13 | 2002-07-02 | The Regents Of The University Of Michigan | Benzimidazole derivatives for the treatment of viral infections |
SK285228B6 (sk) * | 1997-05-13 | 2006-09-07 | Lonza Ag | Spôsob výroby racemického alebo opticky aktívnehoderivátu 4-(hydroxymetyl)-2-cyklopenténu a racemicky N-butyryl-1-amino-4- (hydroxymetyl)-2-cyklopentén |
JP4548866B2 (ja) | 1997-06-10 | 2010-09-22 | グラクソ グループ リミテッド | ベンゾイミダゾール誘導体 |
US6455506B1 (en) | 1997-07-30 | 2002-09-24 | Smithkline Beecham Corporation | Lyxofuranosyl benzimidazoles as antiviral agents |
US6514979B1 (en) | 1999-03-03 | 2003-02-04 | University Of Maryland Biotechnology Institute | Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor |
GB0008939D0 (en) | 2000-04-11 | 2000-05-31 | Glaxo Group Ltd | Process for preparing substituted benzimidazole compounds |
CN100457118C (zh) | 2000-04-13 | 2009-02-04 | 法玛塞特有限公司 | 用于治疗肝炎病毒感染的3′-或2′-羟甲基取代的核苷衍生物 |
TW200831081A (en) | 2006-12-25 | 2008-08-01 | Kyorin Seiyaku Kk | Glucokinase activator |
CN103483342B (zh) * | 2007-08-02 | 2016-08-31 | 米伦纽姆医药公司 | 合成e1活化酶抑制剂的方法 |
AR074619A1 (es) | 2008-04-28 | 2011-02-02 | Teijin Pharma Ltd | Derivados de ciclopentilacrilamida |
US11499722B2 (en) * | 2020-04-30 | 2022-11-15 | Bsh Home Appliances Corporation | Household cooking appliance having an oven door with an interior camera |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4996308A (en) * | 1988-03-25 | 1991-02-26 | Merrell Dow Pharmaceuticals Inc. | Derivatives with unsaturated substitutions for the 5'-hydroxymethyl group |
ZA894534B (en) * | 1988-06-20 | 1990-03-28 | Merrell Dow Pharma | Novel neplanocin derivatives |
GB8826205D0 (en) * | 1988-11-09 | 1988-12-14 | Wellcome Found | Heterocyclic compounds |
GB8926417D0 (en) * | 1989-11-22 | 1990-01-10 | Wellcome Found | Heterocyclic compounds |
MY104575A (en) * | 1989-12-22 | 1994-04-30 | The Wellcome Foundation Ltd | Therapeutic nucleosides. |
US5248672A (en) * | 1990-11-01 | 1993-09-28 | The Regents Of The University Of Michigan | Polysubstituted benzimidazole nucleosides as antiviral agents |
GB9205071D0 (en) * | 1992-03-09 | 1992-04-22 | Wellcome Found | Therapeutic nucleosides |
-
1992
- 1992-03-09 GB GB929205071A patent/GB9205071D0/en active Pending
-
1993
- 1993-03-08 JP JP51547193A patent/JP3450854B2/ja not_active Expired - Fee Related
- 1993-03-08 CA CA002131693A patent/CA2131693A1/en not_active Abandoned
- 1993-03-08 NZ NZ249554A patent/NZ249554A/en unknown
- 1993-03-08 DE DE69320945T patent/DE69320945T2/de not_active Expired - Fee Related
- 1993-03-08 AT AT93905536T patent/ATE170846T1/de not_active IP Right Cessation
- 1993-03-08 HU HU9402582A patent/HUT68445A/hu unknown
- 1993-03-08 IL IL10497693A patent/IL104976A/en not_active IP Right Cessation
- 1993-03-08 AU AU36432/93A patent/AU672597B2/en not_active Ceased
- 1993-03-08 WO PCT/GB1993/000479 patent/WO1993018009A1/en active IP Right Grant
- 1993-03-08 ZA ZA931647A patent/ZA931647B/xx unknown
- 1993-03-08 CZ CZ942094A patent/CZ209494A3/cs unknown
- 1993-03-08 RU RU94043771A patent/RU2141952C1/ru active
- 1993-03-08 DK DK93905536T patent/DK0630368T3/da active
- 1993-03-08 ES ES93905536T patent/ES2123048T3/es not_active Expired - Lifetime
- 1993-03-08 EP EP93905536A patent/EP0630368B1/en not_active Expired - Lifetime
- 1993-05-27 TW TW082104263A patent/TW366339B/zh active
-
1994
- 1994-09-08 FI FI944134A patent/FI944134A/fi unknown
- 1994-09-09 US US08/304,006 patent/US5534535A/en not_active Expired - Lifetime
- 1994-09-09 KR KR1019940703149A patent/KR950700887A/ko not_active Application Discontinuation
-
1995
- 1995-09-11 KR KR1019970701554A patent/KR970705547A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL104976A (en) | 1998-10-30 |
RU2141952C1 (ru) | 1999-11-27 |
KR950700887A (ko) | 1995-02-20 |
IL104976A0 (en) | 1993-07-08 |
ZA931647B (en) | 1994-09-08 |
EP0630368A1 (en) | 1994-12-28 |
DE69320945T2 (de) | 1999-02-04 |
US5534535A (en) | 1996-07-09 |
ES2123048T3 (es) | 1999-01-01 |
KR970705547A (ko) | 1997-10-09 |
JP3450854B2 (ja) | 2003-09-29 |
AU672597B2 (en) | 1996-10-10 |
TW366339B (en) | 1999-08-11 |
DE69320945D1 (de) | 1998-10-15 |
AU3643293A (en) | 1993-10-05 |
ATE170846T1 (de) | 1998-09-15 |
HUT68445A (en) | 1995-06-28 |
CZ209494A3 (en) | 1995-11-15 |
HU9402582D0 (en) | 1994-11-28 |
WO1993018009A1 (en) | 1993-09-16 |
GB9205071D0 (en) | 1992-04-22 |
CA2131693A1 (en) | 1993-09-16 |
NZ249554A (en) | 1996-05-28 |
JPH07506816A (ja) | 1995-07-27 |
FI944134A (fi) | 1994-11-07 |
DK0630368T3 (da) | 1999-06-07 |
EP0630368B1 (en) | 1998-09-09 |
FI944134A0 (fi) | 1994-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU94043771A (ru) | Замещенные бензимидазольные соединения, способ лечения, фармацевтическая композиция и способ получения бензимидазольных соединений | |
EA199901031A1 (ru) | Производные бензимидазола | |
NL300247I2 (nl) | 2-Halogeen-9-(2-desoxy-2-fluor-bêta-D-arabinofuranosyl)-adeninenucleosiderivaten. | |
DK118286D0 (da) | Terapeutisk aktive nucleosider, deres anvendelse og farmaceutiske kompositioner indeholdende forbindelserne | |
EA199800943A1 (ru) | Производные мочевины и их применение в качестве ингибиторов инозин-5`-монофосфат- дегидрогеназы | |
RU94046306A (ru) | Производные индолокарбазолимида, смесь их изомеров или отдельные изомеры и их соли и фармацевтическая композиция с активностью, ингибирующей протеинкиназу с или киназу легкой миозиновой цепи или подавляющей иммунные реакции | |
ES2067508T3 (es) | Dihidroisoquinolinonas sustituidas y compuestos relacionados como potenciadores de los efectos letales de la radiacion y de ciertos agentes quimioterapeuticos; compuestos seleccionados, analogos y proceso. | |
KR950700298A (ko) | 뉴클레오시드 치료제(Therapeutic Nucleosides) | |
PA8483101A1 (es) | Compuestos quimicos | |
EA200200247A1 (ru) | Производные арилметилкарбониламинотиазола и их применение в качестве противоопухолевых средств | |
RU95108243A (ru) | Производные амидов вальпроновой и 2-вальпроеновой кислоты, фармацевтическая композиция, способы лечения | |
ATE20748T1 (de) | Guaninderivate. | |
SE8900192L (sv) | Dideoxididehydrokarbocykliska nukleosider | |
KR880013937A (ko) | 옥세타노신 유도체 | |
RU94038256A (ru) | Производные пиразолопиримидина, способ их получения, фармацевтические композиции на их основе | |
DK468288D0 (da) | Antivirale forbindelser | |
EA200000996A1 (ru) | Конденсированные с арилом азаполициклические соединения | |
RU94035964A (ru) | Производные бензопирана, фармацевтическая композиция на их основе, способ их получения, способ лечения и способ получения промежуточного продукта | |
KR900700495A (ko) | 치료제로서 유용한 치환된 아데닌 유도체 | |
RU94039545A (ru) | Новые производные аденозина, способы их получения, фармацевтические композиции на их основе, способы получения фармацевтических композиций и их применение | |
EA199800526A1 (ru) | Производные бензимидазола и их применение для лечения вирусных инфекций | |
KR900009083A (ko) | 2', 3'-디데옥시푸린 뉴클레오사이드/푸린 뉴클레오 사이드 포스포릴라제 억제제 배합 치료법 및 조성물 | |
DK178188A (da) | Antivirusmiddel | |
ES2105923A1 (es) | Composiciones para el tratamiento de una infeccion y una enfermedad causadas por el virus de la hepatitis b (hbv). | |
DE3273975D1 (de) | Antiviral alpha, alpha-dialkyl adamantylethylamines |